Scientific references

References to Osteoblast Specific Factor 2 (OSF-2, Periostin, Fasciclin-I like) Human (E. coli)

• Erkan M, Kleeff J, Gorbachevski A, Reiser C, Mitkus T, Esposito I, Giese T, Büchler MW, Giese NA, Friess H . Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
• Kuhn B, Del Monte F, Hajjar RJ, Chang YS, Lebeche D, Arab S, Keating MT . Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med . Jul 15 (2007)
• Butcher JT, Norris RA, Hoffman S, Mjaatvedt CH, Markwald RR . Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol . Oct 4 (2006)

References to Osteoblast Specific Factor 2 (OSF-2, Periostin, Fasciclin-I like) Human, Rabbit Polyclonal Antibody

• Castronovo V, Waltregny D, Kischel P, Roesli C, Elia G, Rybak JN, Neri D . A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Mol Cell Proteomics . Nov;5(11):2083-91
• Li P, Oparil S, Novak L, Cao X, Shi W, Lucas J, Chen YF . ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells. J Appl Physiol . Jan;102(1):390-8 (2007)
• Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'hare MJ . Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Rest . Oct 2;8(5):R56 (2006)
• Blumer MJ, Schwarzer C, Perez MT, Konakci KZ, Fritsch H . Identification and location of bone-forming cells within cartilage canals on their course into the secondary ossification centre. J Anat . Jun;208(6):695-707 (2006)
• Hosoya A, Nakamura H, Ninomiya T, Yoshiba K, Yoshiba N, Nakaya H, Wakitani S, Yamada H, Kasahara E, Ozawa H . Immunohistochemical localization of alpha-Smooth muscle actin during rat molar tooth development. J Histochem Cytochem . Dec;54(12):1371-8 (2006)
• Erkan M, Kleeff J, Gorbachevski A, Reiser C, Mitkus T, Esposito I, Giese T, Büchler MW, Giese NA, Friess H . Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
• Liang X, Zhao J, Hajivandi M, Wu R, Tao J, Amshey JW, Pope RM . Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma. J Proteome Res . Oct;5(10):2632-41 (2006)
• Zhang GY, Zhang YN, Li JS, Tang WH . The expression analysis of periostin in human breast cancer tissues.
• Sun GW, Li JS, TangWH . The Expression and Significance of Periostin in Human Gastric Carcinoma.

References to Osteoprotegerin Human ELISA

• Clancy P, Oliver L, Jayalath R, Buttner P, Golledge J . Assessment of a serum assay for quantification of abdominal aortic calcification. Arterioscler Thromb Vasc Biol . Nov;26(11):2574-6 (2006)
• Maimoun L, Couret I, Mariano-Goulart D, Dupuy AM, Micallef JP, Peruchon E, Ohanna F, Cristol JP, Rossi M, Leroux JL. Changes in osteoprotegerin/RANKL system, bone mineral density, and bone biochemicals markers in patients with recent spinal cord injury. Calcif Tissue Int. 2005 Jun;76 (6):404-11
• Rogers A, Eastell R. Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab. 2005 Nov;90 (11):6323-31
• Kanzaki H, Chiba M, Sato A, Miyagawa A, Arai K, Nukatsuka S, Mitani H. Cyclical tensile force on periodontal ligament cells inhibits osteoclastogenesis through OPG induction. J Dent Res. 2006 May;85 (5):457-62
• Avbersek-Luznik I, Balon BP, Rus I, Marc J. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?. Nephrol Dial Transplant. 2005 Mar;20 (3):566-70
• Dai SM, Nishioka K, Yudoh K. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Ann Rheum Dis. 2004 Nov;63 (11):1379-86
• Skladal P, Jilkova Z, Svoboda I, Kolar V. Investigation of osteoprotegerin interactions with ligands and antibodies using piezoelectric biosensors. Biosens Bioelectron. 2005 Apr 15;20 (10):2027-34
• Stejskal D, Zurek M, Bartek J, Jedelsky L, Ruzicka V. Osteoprotegerin and bone density. Biomed Pap Med Fac Univ Palack. 2001 Dec;145 (2):75-6
• Ozkaya O, Buyan N, Bideci A, Gonen S, Ortac E, Fidan K, Cinaz P, Soylemezoglu O. Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis. Nephron Clin Pract. 2007;105 (4):c153-8
• Avignon A, Sultan A, Piot C, Elaerts S, Cristol JP, Dupuy AM. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care. 2005 Sep;28 (9):2176-80
• Gogo PB Jr, Schneider DJ, Terrien EF, Sobel BE, Dauerman HL. Osteoprotegerin is not associated with angiographic coronary calcification. J Thromb Thrombolysis. 2006 Dec;22 (3):177-83
• Stejskal D, Bartek J, Pastorkova R, Ruzicka V, Oral I, Horalik D. Osteoprotegerin, RANK, RANKL. Biomed Pap Med Fac Univ Palack. 2001 Dec;145 (2):61-4
• Morena M, Terrier N, Jaussent I, Leray-Moragues H, Chalabi L, Rivory JP, Maurice F, Delcourt C, Cristol JP, Canaud B, Dupuy AM. Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol. 2006 Jan;17 (1):262-70
• Golledge J, Jayalath R, Oliver L, Parr A, Schurgers L, Clancy P. Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. Atherosclerosis. 2008 Mar;197 (1):428-34
• Garcia-Valdecasas-Campelo E, Gonzalez-Reimers E, Santolaria-Fernandez F, De la Vega-Prieto MJ, Milena-Abril A, Sanchez-Perez MJ, Martinez-Riera A, Gomez-Rodriguez Mde L. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. Alcohol Alcohol. 2006 May-Jun;41 (3):261-6
• Kim SM, Lee J, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Clin Endocrinol (Oxf). 2005 Nov;63 (5):594-8
• Guldiken B, Guldiken S, Turgut B, Turgut N, Demir M, Celik Y, Arikan E, Tugrul A. Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct. Thromb Res. 2007;120 (4):511-6
• Kyrtsonis MC, Vassilakopoulos TP, Siakantaris MP, Kokoris SI, Gribabis DA, Dimopoulou MN, Angelopoulou MK, Pangalis GA. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease. Eur J Haematol. 2004 Apr;72 (4):252-8